Dudediligence.

Xenetic Biosciences, Inc

XBIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$614,243Sep ’24$648,820Dec ’24$593,261Mar ’25$589,897Jun ’25$1.0MSep ’25$766,296Dec ’25$806,923Mar ’26$660,601Jun ’26
Net income, by quarter
−$436,671Sep ’24−$1.1MDec ’24−$903,141Mar ’25−$688,703Jun ’25−$509,940Sep ’25−$579,076Dec ’25−$456,382Mar ’26−$929,695Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.2M$1.7M$2.5M$2.5M$3.0M
Operating income−$5.7M−$6.7M−$4.5M−$4.2M−$2.8M
Net income−$5.6M−$6.6M−$4.1M−$4.0M−$2.7M
Operating cash flow−$4.7M−$4.6M−$4.1M−$2.8M−$2.3M
Cash$18.2M$13.1M$9.0M$6.2M$7.9M
Shares outstanding13.4M1.5M1.5M1.5M2.3M